by Neoteryx, on April 22,2021
At the end of March 2021, Quanterix Corporation issued a press release announcing that its Simoa® technology had been used in a research study to detect the SARS-CoV-2 virus. According …
Read Storyby Neoteryx, on March 25,2021
According to a March 12, 2021 article by Adam Bonislawski in Genomeweb, researchers at Stanford University are profiling responses to the COVID-19 vaccinations. The Stanford study investigates the effects of …
Read Storyby Neoteryx, on March 17,2021
AUCKLAND, NEW ZEALAND – March 2021 – New Zealand has proved to be one of the most successful nations in responding effectively to the coronavirus pandemic and controlling the spread …
Read Storyby Neoteryx, on February 5,2021
LONDON — February 2021 — A home specimen collection service launched in late 2020 by Guy's and St Thomas, an NHS Foundation Trust hospital in London, is designed to keep …
Read Storyby Neoteryx, on January 4,2021
Mitra Microsamples Help NIH Measure SARS-CoV-2 Raised Antibodies With 99-100% Accuracy LOS ANGELES / BETHESDA, MD — JANUARY 4, 2021 — After launching a “serosurvey” to track undetected cases of …
Read Story